Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in … Read more
Rapid Dose Therapeutics Corp (RDTCF) - Total Liabilities
Latest total liabilities as of November 2025: $10.43 Million USD
Based on the latest financial reports, Rapid Dose Therapeutics Corp (RDTCF) has total liabilities worth $10.43 Million USD as of November 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Rapid Dose Therapeutics Corp - Total Liabilities Trend (2009–2025)
This chart illustrates how Rapid Dose Therapeutics Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Rapid Dose Therapeutics Corp Competitors by Total Liabilities
The table below lists competitors of Rapid Dose Therapeutics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Woory Industrial Holdings Co.Ltd
KQ:072470
|
Korea | ₩337.09 Billion |
|
Urbas Grupo Financiero SA
MC:UBS
|
Spain | €415.90 Million |
|
Ieh Corp
PINK:IEHC
|
USA | $3.81 Billion |
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
India | ₹7.29 Billion |
|
Remsons Industries Limited
NSE:REMSONSIND
|
India | ₹2.09 Billion |
|
Cloudastructure, Inc. Class A Common Stock
NASDAQ:CSAI
|
USA | $1.89 Million |
|
Zeo ScientifiX, Inc.
OTCQB:ZEOX
|
USA | $2.95 Million |
|
Galileo Mining Ltd
AU:GAL
|
Australia | AU$653.15K |
Liability Composition Analysis (2009–2025)
This chart breaks down Rapid Dose Therapeutics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Rapid Dose Therapeutics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Rapid Dose Therapeutics Corp (2009–2025)
The table below shows the annual total liabilities of Rapid Dose Therapeutics Corp from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-02-28 | $6.84 Million | +35.64% |
| 2024-02-29 | $5.04 Million | +2.57% |
| 2023-02-28 | $4.92 Million | +74.56% |
| 2022-02-28 | $2.82 Million | -42.77% |
| 2021-02-28 | $4.92 Million | +10.91% |
| 2020-02-29 | $4.44 Million | +126.92% |
| 2019-02-28 | $1.96 Million | +6453.81% |
| 2018-02-28 | $29.84K | -20.96% |
| 2017-02-28 | $37.75K | +60.29% |
| 2016-02-29 | $23.55K | -17.92% |
| 2015-02-28 | $28.69K | -2.30% |
| 2014-02-28 | $29.37K | -32.16% |
| 2013-02-28 | $43.29K | -18.78% |
| 2012-02-29 | $53.30K | +348.57% |
| 2011-02-28 | $11.88K | -50.64% |
| 2010-02-28 | $24.08K | +381.52% |
| 2009-02-28 | $5.00K | -- |